arrow
M

Megan S. Lim

Memorial Sloan Kettering Cancer Center
H指数:61
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response

霍奇金淋巴瘤霍奇金和里德-斯滕伯格细胞的转录组测序揭示NK细胞识别逃逸和未折叠蛋白反应

2026-04-220
OAAI
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis

CXCL9作为一种新型预后标志物,用于识别患有噬血细胞性淋巴组织细胞增多症的成人高风险群体。

Blood
IF23.1
2026-02-263
PRE
Idiopathic Multicentric Castleman Disease Unresponsive to One IL-6 Inhibitor May Respond to Another IL-6 Inhibitor

原发性多中心性Castleman病对一种IL-6抑制剂无反应可能对另一种IL-6抑制剂有反应

2026-01-010
OAAI
B-Cell Lymphomas 3.2025 Featured Updates to the NCCN Guidelines

B细胞淋巴瘤 3.2025 NCCN指南特色更新

2025-10-010
PRE
The Development of Diagnostic Criteria and Utilization of Excisional Lymph Node Biopsies Shorten Time to Diagnosis for Idiopathic Multicentric Castleman Disease

诊断标准的发展和切除性淋巴结活检的应用缩短了特发性多中心性Castleman病的诊断时间

BLOOD
IF23.1
2024-11-050
PRE
EBV prevalence and overall survival in the MultiEthnic Study of Hodgkin lymphoma (MESH)
2024-09-210
PRE
B-Cell Lymphomas, Version 6.2023 Featured Updates to the NCCN Guidelines

B细胞淋巴瘤,6.2023版更新了NCCN指南

2023-11-0126
OA
The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)

世界卫生组织第5版血淋巴肿瘤分类: 淋巴肿瘤 (第36卷,1720页,2022)

LEUKEMIA
IF13.4
2023-07-1915
OAAI